Status:
COMPLETED
Acute Normovolemic Hemodilution (ANH) in Patients Undergoing Cardiac Surgery
Lead Sponsor:
University of Minnesota
Conditions:
Surgery--Complications
Blood Transfusion Complication
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this small randomized pilot study is to evaluate adherence to strict transfusion protocols in both the control and ANH group examining compliant and noncompliant transfusion rates and r...
Detailed Description
Cardiac surgery patients are typically at higher risk of receiving blood transfusions during surgery than patients presenting for most other surgical procedures. Acute normovolemic hemodilution (ANH) ...
Eligibility Criteria
Inclusion
- \- Patients undergoing cardiac surgery involving one of the following procedures at the University of Minnesota: A) combined coronary artery bypass graft and valve repair/replacement B) redo cardiac surgery C) left ventricular assist device placement
Exclusion
- Hemoglobin concentration \< 12 g/dl
- Patients undergoing cardiac surgery without the use of cardiopulmonary bypass
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT04127825
Start Date
November 1 2017
End Date
April 30 2021
Last Update
March 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota Medical Center
Minneapolis, Minnesota, United States, 55455